WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate ...

A new rapid test for Valley Fever developed in Phoenix is getting ready to go on the market and will be a game-changer for ...

In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...

OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...

Arizona advances in fighting Valley Fever with a new rapid test developed by Dr. Thomas Grys of the Mayo Clinic and ASU, ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use ...

Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...

IIT Ropar researchers developed boronopeptides that detect Gram-positive bacteria about 40× more accurately and faster than current tests, enabling quicker diagnosis and better antibiotic use.

A significant number of Tuberculosis (TB) cases go undetected due to the limited sensitivity of smear microscopy, the most common diagnostic test for TB in India.